Probucol combined with valsartan in immunoglobulin A nephropathy: A multi-centre, open labelled, randomized controlled study-Reference-Cited by-同舟云学术

Probucol combined with valsartan in immunoglobulin A nephropathy: A multi-centre, open labelled, randomized controlled study

Published:2013-12-17 Issue:1 Volume:19 Page:40-46
ISSN:1320-5358
Container-title:Nephrology
language:en
Short-container-title:Nephrology

Author:

Ye Zhiming¹²,Zhang Li¹²,Xu Lixia²,Shi Wei²,Hu Haitang³,Shi Xiaofeng⁴,Zhong Weiqiang⁵,Hou Shuan⁶,Yan Honghong²,Zhang Bin²,Xia Yunfeng²,Wang Wenjian²,Feng Zonglin²,Wang Liping²,Liang Yongzheng²

Affiliation:

1. Southern Medical University; Guangzhou China

2. Department of Nephrology; Guangdong General Hospital, Guangdong Academy of Medical Sciences; Guangzhou China

3. Department of Nephrology; The First People's Hospital of Shunde; Foshan China

4. Department of Nephrology; Jiangmen Central Hospital; Jiangmen China

5. Department of Nephrology; Huizhou People's Hospital; Huizhou China

6. Depatrtment of Nephrology; Shenzhen Hospital of Piking University; Shenzhen China

Publisher

Wiley

Subject

Nephrology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/nep.12177/fullpdf

Reference31 articles.

1. IgA nephropathy;Barratt;J. Am. Soc. Nephrol.,2005

2. Immunoglobulin A nephropathy and chronic kidney disease;Tomino;Nephrology (Carlton),2010

3. The pathophysiology of IgA nephropathy;Suzuki;J. Am. Soc. Nephrol.,2011

4. An update on the pathogenesis and treatment of IgA nephropathy;Boyd;Kidney Int.,2012

5. Current therapy for IgA nephropathy;Floege;J. Am. Soc. Nephrol.,2011

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-immunosuppressive treatment for IgA nephropathy;Cochrane Database of Systematic Reviews;2024-02-01

2. Drug Therapies for Patients with IgA Nephropathy: A Network Meta-analysis of Randomized Clinical Trials;Current Clinical Pharmacology;2020-10-14

3. Probucol for the prevention of contrast-induced acute kidney injury in patients undergoing coronary angiography or percutaneous coronary intervention: A meta-analysis of randomized controlled trials;Clinical Nephrology;2019-07-01

4. Low molecule weight fucoidan mitigates atherosclerosis in ApoE (-/-) mouse model through activating multiple signal pathway;Carbohydrate Polymers;2019-02

5. Drugs for Treatment of Dyslipidemia Available in the USA;Endocrine Disorders in Kidney Disease;2019